Head-to-head · WeighScore
Jently vs PepHaūs
By GLP-1 ScorecardUpdated
Score comparison
PepHaūs has the higher recorded score — 82.7/100 to 67/100.
PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Verified and nationwide, but priced in the upper-mid band ($152/$246).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Jently | PepHaūs |
|---|---|---|
| WeighScore | 67/100 | 82.7/100 |
| Grade | C | B− |
| Site position | #190 | #27 |
| Semaglutide | $149/mo (starting dose, compounded) | $152/mo |
| Tirzepatide | $199/mo (starting dose, compounded) | $246/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #190 · C
Strengths
- Compounded semaglutide from $149/mo and tirzepatide from $199/mo — pricing published
- Multi-pillar: GLP-1, NAD+, peptides (sermorelin, glutathione), and metformin
- 100% online with licensed providers via the MD Integrations network
- Subscription can be canceled anytime through the patient portal
What to consider
- Specific pharmacy partner not named on the site
- No refunds once a consultation is completed or a prescription is dispensed
- LegitScript certification was not documented on the public pages reviewed
- States of operation not published
Site position #27 · B−
Strengths
- LegitScript-verified, all 50 states
- Both molecules
- Transparent listed pricing
What to consider
- Upper-mid pricing ($152/$246)
- Injection-only
- Monitoring detail limited
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.